Trilogy Capital’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.53M | Buy |
44,531
+33,904
| +319% | +$2.68M | 0.17% | 83 |
|
|
2025
Q1 | $954K | Buy |
10,627
+458
| +5% | +$41.1K | 0.05% | 179 |
|
|
2024
Q4 | $1.01M | Sell |
10,169
-1,868
| -16% | -$186K | 0.05% | 175 |
|
|
2024
Q3 | $1.37M | Sell |
12,037
-225
| -2% | -$25.6K | 0.07% | 165 |
|
|
2024
Q2 | $1.52M | Buy |
12,262
+6,360
| +108% | +$787K | 0.08% | 145 |
|
|
2024
Q1 | $779K | Buy |
5,902
+3,112
| +112% | +$411K | 0.04% | 164 |
|
|
2023
Q4 | $304K | Buy |
2,790
+437
| +19% | +$47.6K | 0.02% | 209 |
|
|
2023
Q3 | $242K | Sell |
2,353
-986
| -30% | -$102K | 0.02% | 236 |
|
|
2023
Q2 | $369K | Buy |
3,339
+578
| +21% | +$63.8K | 0.02% | 198 |
|
|
2023
Q1 | $294K | Sell |
2,761
-3,221
| -54% | -$343K | 0.02% | 219 |
|
|
2022
Q4 | $664K | Buy |
5,982
+2,334
| +64% | +$259K | 0.05% | 146 |
|
|
2022
Q3 | $314K | Buy |
3,648
+155
| +4% | +$13.3K | 0.03% | 147 |
|
|
2022
Q2 | $318K | Buy |
3,493
+285
| +9% | +$25.9K | 0.03% | 133 |
|
|
2022
Q1 | $263K | Buy |
+3,208
| New | +$263K | 0.02% | 152 |
|
|
2019
Q1 | – | Sell |
-10,383
| Closed | -$757K | – | 150 |
|
|
2018
Q4 | $757K | Sell |
10,383
-832
| -7% | -$60.7K | 0.1% | 71 |
|
|
2018
Q3 | $759K | Sell |
11,215
-1,353
| -11% | -$91.6K | 0.09% | 75 |
|
|
2018
Q2 | $728K | Sell |
12,568
-234
| -2% | -$13.6K | 0.1% | 60 |
|
|
2018
Q1 | $665K | Buy |
+12,802
| New | +$665K | 0.1% | 66 |
|